METABOLISM OF AMITRIPTYLINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引:22
作者
SANDOZ, M
VANDEL, S
VANDEL, B
BONIN, B
HORY, B
HILLIER, YS
VOLMAT, R
机构
[1] CHU BESANCON,PHARMACOL CLIN LAB,F-25030 BESANCON,FRANCE
[2] CHU BESANCON,NEUROL & PSYCHIAT CLIN,F-25030 BESANCON,FRANCE
[3] CHU BESANCON,SERV MED 5,F-25030 BESANCON,FRANCE
关键词
D O I
10.1007/BF00630290
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:227 / 232
页数:6
相关论文
共 60 条
  • [1] URINARY-EXCRETION OF NORTRIPTYLINE AND 5 OF ITS METABOLITES IN MAN AFTER SINGLE AND MULTIPLE ORAL DOSES
    ALEXANDERSON, B
    BORGA, O
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1973, 5 (03) : 174 - 180
  • [2] ASBERG M, 1981, THER DRUG MONIT, P224
  • [3] GUIDELINES FOR DRUG-THERAPY IN RENAL-FAILURE
    BENNETT, WM
    SINGER, I
    GOLPER, T
    FEIG, P
    COGGINS, CJ
    [J]. ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) : 754 - 783
  • [4] PRONOUNCED INHIBITION OF NORADRENALINE UPTAKE BY 10-HYDROXY-METABOLITES OF NORTRIPTYLINE
    BERTILSSON, L
    MELLSTROM, B
    SJOQVIST, F
    [J]. LIFE SCIENCES, 1979, 25 (15) : 1285 - 1292
  • [5] NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN
    BERTILSSON, L
    EICHELBAUM, M
    MELLSTROM, B
    SAWE, J
    SCHULZ, HU
    SJOQVIST, F
    [J]. LIFE SCIENCES, 1980, 27 (18) : 1673 - 1677
  • [6] BERTILSSON L, 1982, ADV BIOSCIENCES, V40
  • [7] BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004
  • [8] BIGGS SR, 1979, DRUG METAB DISPOS, V7, P233
  • [9] BORGA O, 1979, CLIN PHARMACOL THER, V26, P306
  • [10] BRAITHWAITE RA, 1976, BR J CLIN PHARM S, P29